...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Corporate Update Webcast... 11:00 MT/1:00 ET... Link-->

Slides are on the Zenith website now and also linked here and added to the link library/due diligence on the Zenith Agoracom hub.

BearDownAZ

8
Jun 21, 2016 12:10PM
5
Jun 21, 2016 04:42PM
Share
New Message
Please login to post a reply